Bruker Cellular Analysis Competitors and Similar CompaniesClear all
Sangamo Therapeutics's competitors and similar companies include GenScript and Crescendo Biologics.
 Sangamo Therapeutics Sangamo Therapeutics (formerly known as Sangamo BioSciences) is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies. |  GenScript Genscript Biotech is a biotech company focusing on early drug discovery and development services. |  Crescendo Biologics Crescendo Biologics is a provider of human VH antibody fragment therapeutics created to optimize antibodies and a transgenic mouse which produces heavy chain only antibodies. | |
Founding Date | Founding Date 1995 | Founding Date 2002 | Founding Date 2007 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Brisbane, US HQ Nice Area, FR Cheltenham, GB London, GB Richmond, US | Locations Babraham, GB HQ | |
Employees | Employees 35417% increase | Employees 6,16511% increase | Employees 12 |
Financial | |||
Revenue (est.) | Revenue (est.) $39.6m (FY, 2025) | Revenue (est.) $959.5m (FY, 2025) | Revenue (est.) £7.5m (FY, 2018) |
Cost of goods | Cost of goods N/A | Cost of goods $332.3m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $650.8m (FY, 2025) | Gross profit £7.5m (FY, 2018) |
Net income | Net income ($122.9m) (FY, 2025) | Net income ($532.4m) (FY, 2025) | Net income (£1.8m) (FY, 2018) |
Funding | |||
Total funding raised | Total funding raised $ 74.2m | Total funding raised N/A | Total funding raised $ 116.2m |
For sources of this data, please see the company profile
View Company Profiles
GenScript
HQ
George Town, KY
Employees
6,165↑ 11% increase
Genscript Biotech is a biotech company focusing on early drug discovery and development services.
View companyCrescendo Biologics
HQ
Babraham, GB
Employees
12
Crescendo Biologics is a provider of human VH antibody fragment therapeutics created to optimize antibodies and a transgenic mouse which produces heavy chain only antibodies.
View company